It’s be­gin­ning to look a lot like M&A sea­son; Aduhelm runs in­to more re­sis­tance; Eli Lil­ly, Bris­tol My­ers get in ear­ly on can­cer ef­forts; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

As JP Mor­gan moves #JPM22 ful­ly vir­tu­al, so will End­points News. We’re tak­ing our mul­ti-day hy­brid event sched­ule on­line, with no live cock­tail hour or net­work­ing events but plen­ty of time­ly news, in­sight­ful pan­els and fire­side chats pre­view­ing the new year. We’ll be sad to not see our friends and col­leagues on site, but we en­cour­age every­one to still reg­is­ter for the event and join the con­ver­sa­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.